Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE)

Publikation: Bidrag til tidsskriftReviewForskning

Standard

Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE). / Juul, Anders; Bernasconi, Sergio; Carel, Jean-Claude; Clayton, Peter E; Kiess, Wieland; DeMuinck-Keizer Schrama, Sabine; Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology.

I: Hormone Research, Bind 60, Nr. 2, 2003, s. 103-4.

Publikation: Bidrag til tidsskriftReviewForskning

Harvard

Juul, A, Bernasconi, S, Carel, J-C, Clayton, PE, Kiess, W, DeMuinck-Keizer Schrama, S & Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology 2003, 'Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE)', Hormone Research, bind 60, nr. 2, s. 103-4. https://doi.org/71879

APA

Juul, A., Bernasconi, S., Carel, J-C., Clayton, P. E., Kiess, W., DeMuinck-Keizer Schrama, S., & Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (2003). Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE). Hormone Research, 60(2), 103-4. https://doi.org/71879

Vancouver

Juul A, Bernasconi S, Carel J-C, Clayton PE, Kiess W, DeMuinck-Keizer Schrama S o.a. Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE). Hormone Research. 2003;60(2):103-4. https://doi.org/71879

Author

Juul, Anders ; Bernasconi, Sergio ; Carel, Jean-Claude ; Clayton, Peter E ; Kiess, Wieland ; DeMuinck-Keizer Schrama, Sabine ; Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology. / Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE). I: Hormone Research. 2003 ; Bind 60, Nr. 2. s. 103-4.

Bibtex

@article{8377186ae1b14d23bec323ce63c1095b,
title = "Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE)",
author = "Anders Juul and Sergio Bernasconi and Jean-Claude Carel and Clayton, {Peter E} and Wieland Kiess and {DeMuinck-Keizer Schrama}, Sabine and Anders Juul",
year = "2003",
doi = "http://dx.doi.org/71879",
language = "English",
volume = "60",
pages = "103--4",
journal = "Hormone Research",
issn = "0301-0163",
publisher = "S./Karger AG",
number = "2",

}

RIS

TY - JOUR

T1 - Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE)

AU - Juul, Anders

AU - Bernasconi, Sergio

AU - Carel, Jean-Claude

AU - Clayton, Peter E

AU - Kiess, Wieland

AU - DeMuinck-Keizer Schrama, Sabine

AU - Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology

PY - 2003

Y1 - 2003

U2 - http://dx.doi.org/71879

DO - http://dx.doi.org/71879

M3 - Review

VL - 60

SP - 103

EP - 104

JO - Hormone Research

JF - Hormone Research

SN - 0301-0163

IS - 2

ER -

ID: 48484066